Inhibition of formyl peptide-stimulated phospholipase D activation by Fal-002-2 via blockade of the Arf6, RhoA and protein kinase C signaling pathways in rat neutrophils
详细信息    查看全文
  • 作者:Ya-Ru Tsai (1)
    Li-Jiau Huang (2)
    Hui-Yi Lin (2)
    Yun-Jie Hung (1)
    Miau-Rong Lee (3)
    Sheng-Chu Kuo (2)
    Mei-Feng Hsu (3)
    Jih-Pyang Wang (1)
  • 关键词:Fal ; 002 ; 2 ; Phospholipase D ; RhoA ; Arf6 ; Protein kinase C ; Neutrophils ; Superoxide anion
  • 刊名:Naunyn-Schmiedeberg's Archives of Pharmacology
  • 出版年:2013
  • 出版时间:June 2013
  • 年:2013
  • 卷:386
  • 期:6
  • 页码:507-519
  • 全文大小:730KB
  • 参考文献:1. Aghazadeh B, Lowry WE, Huang XY, Rosen MK (2000) Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation. Cell 102:625-33 CrossRef
    2. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG (2001) Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 154:1007-017 CrossRef
    3. Chang LC, Chen CM, Wang JP (2003) Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated of phospholipase D activation in rat neutrophils by the synthetic isoquinoline DMDI. Biochim Biophys Acta 1620:191-98 CrossRef
    4. Chang LC, Huang TH, Chang CS, Tsai YR, Lin RH, Lee PW, Hsu MF, Huang LJ, Wang JP (2011) Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils. Biochem Pharmacol 81:269-78 CrossRef
    5. Chardin P, Paris S, Antonny B, Robineau S, Béraud-Dufour S, Jackson CL, Chabre M (1996) A human exchange factor for ARF contains Sec7- and pleckstrin-homology domains. Nature 384:481-84 CrossRef
    6. Cross AR, Segal AW (2004) The NADPH oxidase of professional phagocytes—prototype of the NOX electron transport chain systems. Biochim Biophys Acta 1657:1-2
    7. Donaldson JG (2003) Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 278:41573-1576 CrossRef
    8. Donaldson JG, Jackson CL (2011) ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol 12:362-75 CrossRef
    9. D’Souza-Schorey C, Chavrier P (2006) ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7:347-58 CrossRef
    10. Franco M, Peters PJ, Boretto J, van Donselaar E, Neri A, D’Souza-Schorey C, Chavrier P (1999) EFA6, a sec7 domain-containing exchange factor for ARF6, coordinates membrane recycling and actin cytoskeleton organization. EMBO J 18:1480-491 CrossRef
    11. Fumagalli L, Zhang H, Baruzzi A, Lowell CA, Berton G (2007) The Src family kinases Hck and Fgr regulate neutrophil responses to / N-formyl-methionyl-leucyl-phenylalanine. J Immunol 178:3874-885
    12. Funakoshi Y, Hasegawa H, Kanaho Y (2010) Activation mechanisms of PIP5K isozymes by the small GTPase ARF6. Adv Enzyme Regul 50:72-0 CrossRef
    13. Gomez-Cambronero J, Di Fulvio M, Knapek K (2007) Understanding phospholipase D (PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis. J Leukoc Biol 82:272-81 CrossRef
    14. Guillemain I, Exton JH (1997) Effects of brefeldin A on phosphatidylcholine phospholipase D and inositolphospholipid metabolism in HL-60 cells. Eur J Biochem 249:812-19 CrossRef
    15. Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-5 CrossRef
    16. Han J, Das B, Wei W, Van Aelst L, Mosteller RD, Khosravi-Far R, Westwick JK, Der CJ, Broek D (1997) Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol 17:1346-353
    17. Houle MG, Naccache PH, Bourgoin S (1999) Tyrosine kinase-regulated small GTPase translocation and the activation of phospholipase D in HL60 granulocytes. J Leukoc Biol 66:1021-030
    18. Jiang H, Luo JQ, Urano T, Frankel P, Lu Z, Foster DA, Feig LA (1995) Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 378:409-12 CrossRef
    19. Kanaho Y, Kobayashi-Nakano A, Yokozeki T (2007) The phosphoinositide kinase PIP5K that produces the versatile signaling phospholipid PI4,5P2. Biol Pharm Bull 30:1605-609 CrossRef
    20. Kanoh H, Williger BT, Exton JH (1997) Arfaptin 1, a putative cytosolic target protein of ADP-ribosylation factor, is recruited to Golgi membranes. J Biol Chem 272:5421-429 CrossRef
    21. Klarlund JK, Tsiaras W, Holik JJ, Chawla A, Czech MP (2000) Distinct polyphosphoinositide binding selectivities for pleckstrin homology domains of GRP1-like proteins based on diglycine versus triglycine motifs. J Biol Chem 275:32816-2821 CrossRef
    22. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M (1997) Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272:12257-2260 CrossRef
    23. Lai YY, Huang LJ, Lee KH, Xiao Z, Bastow KF, Yamori T, Kuo SC (2005) Synthesis and biological relationships of 3-6-substituted 2-phenyl-4-quinolone-3-carboxylic acid derivatives as antimitotic agents. Bioorg Med Chem 13:265-75 CrossRef
    24. Lavieri R, Scott SA, Lewis JA, Selvy PE, Armstrong MD, Brown HA, Lindsley CW (2009) Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors: Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity. Bioorg Med Chem Lett 19:2240-243 CrossRef
    25. Lewis JA, Scott SA, Lavieri R, Buck JR, Selvy PE, Stoops SL, Armstrong MD, Brown HA, Lindsley CW (2009) Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors: Part I. Impact of alternative halogenated privileged structures for PLD1 specificity. Bioorg Med Chem Lett 19:1916-920 CrossRef
    26. Lopez I, Burns DJ, Lambeth JD (1995) Regulation of phospholipase D by protein kinase C in human neutrophils. Conventional isoforms of protein kinase C phosphorylate a phospholipase D-related component in the plasma membrane. J Biol Chem 270:19465-9472 CrossRef
    27. Marcil J, Harbour D, Houle MG, Naccache PH, Bourgoin S (1999) Monosodium urate crystal-stimulated phospholipase D in human neutrophils. Biochem J 337:185-92 CrossRef
    28. McDermott M, Wakelam MJ, Morris AJ (2004) Phospholipase D. Biochem Cell Biol 82:225-53 CrossRef
    29. Norton LJ, Zhang Q, Saqib KM, Schrewe H, Macura K, Anderson KE, Lindsley CW, Brown HA, Rudge SA, Wakelam MJ (2011) PLD1 rather than PLD2 regulates phorbol-ester-, adhesion-dependent and Fcγ-receptor-stimulated ROS production in neutrophils. J Cell Sci 124:1973-983 CrossRef
    30. Paruch S, El-Benna J, Djerdjouri B, Marullo S, Perianin A (2006) A role of p44/42 mitogen-activated protein kinases in formyl-peptide receptor-mediated phospholipase D activity and oxidant production. FASEB J 20:142-44
    31. Rais S, Pedruzzi E, Dang MC, Giroud JP, Hakim J, Perianin A (1998) Priming of phosphatidic acid production by staurosporine in f-Met-Leu-Phe-stimulated human neutrophils: correlation with respiratory burst. Cell Signal 10:121-29 CrossRef
    32. Sato T, Hongu T, Sakamoto M, Funakoshi Y, Kanaho Y (2013) Molecular mechanisms of / N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable. Mol Cell Biol 33:136-45 CrossRef
    33. Someya A, Sata M, Takeda K, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M (2001) ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6. Proc Natl Acad Sci USA 98:2413-418 CrossRef
    34. Song J, Khachikian Z, Radhakrishna H, Donaldson JG (1998) Localization of endogenous ARF6 to sites of cortical actin rearrangement and involvement of ARF6 in cell spreading. J Cell Sci 111:2257-267
    35. Su W, Yeku O, Olepu S, Genna A, Park JS, Ren H, Du G, Gelb MH, Morris AJ, Frohman MA (2009) 5-Fluoro-2-indolyl deschlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol 75:437-46 CrossRef
    36. Tarricone C, Xiao B, Justin N, Walker PA, Rittinger K, Gamblin SJ, Smerdon SJ (2001) The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signaling pathways. Nature 411:215-19 CrossRef
    37. Tsai YR, Huang LJ, Lin HY, Hung YJ, Lee MR, Kuo SC, Hsu MF, Wang JP (2013) Inhibition of formyl peptide-stimulated superoxide anion generation by Fal-002-2 occurs mainly through the blockade of the p21-activated kinase and protein kinase C signaling pathways in rat neutrophils. Eur J Pharmacol 701:114-23 CrossRef
    38. Tsao LT, Wang JP (1997) Translocation of protein kinase C isoforms in rat neutrophils. Biochem Biophys Res Commun 234:412-18 CrossRef
    39. Walker SJ, Brown HA (2002) Specificity of Rho insert-mediated activation of phospholipase D1. J Biol Chem 277:26260-6267 CrossRef
    40. Wang JP, Chang LC, Raung SL, Hsu MF, Huang LJ, Kuo SC (2002) Inhibition of superoxide anion generation by YC-1 in rat neutrophils through cyclic GMP-dependent and -independent mechanisms. Biochem Pharmacol 63:577-85 CrossRef
    41. Williams JC, Wierenga RK, Saraste M (1998) Insights into Src kinase functions: structural comparisons. Trends Biochem Sci 23:179-84 CrossRef
    42. Zeniou-Meyer M, Begle A, Bader MF, Vitale N (2009) The Coffin–Lowry Syndrome-associated protein RSK2 controls neuroendocrine secretion through the regulation of phospholipase D1 at the exocytotic sites. Ann NY Acad Sci 1152:201-08 CrossRef
  • 作者单位:Ya-Ru Tsai (1)
    Li-Jiau Huang (2)
    Hui-Yi Lin (2)
    Yun-Jie Hung (1)
    Miau-Rong Lee (3)
    Sheng-Chu Kuo (2)
    Mei-Feng Hsu (3)
    Jih-Pyang Wang (1)

    1. Department of Medical Research, Taichung Veterans General Hospital, 160, Section 3, Chung Kang Road, Taichung, 407, Taiwan
    2. Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, 404, Taiwan
    3. Department of Biochemistry, China Medical University, Taichung, 404, Taiwan
  • ISSN:1432-1912
文摘
Three recently developed selective phospholipase D (PLD) inhibitors N-(2-(4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)-2-naphthamide (VU0155056), (S)-N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-naphthamide (VU0155069), and N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]decan-8-yl)ethyl)quinoline-3-carboxamide (VU0285655-1) inhibited O2 ?? generation in formyl-Met-Leu-Phe (fMLP)-stimulated rat neutrophils. A novel 2-phenyl-4-quinolone compound 6-chloro-2-(2-chlorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylate (Fal-002-2), which inhibited O2 ?? generation, also reduced the fMLP- but not phorbol ester-stimulated PLD activity (IC50 16.0?±-.0?μM). Fal-002-2 attenuated the interaction of PLD1 with ADP-ribosylation factor (Arf) 6, Ras homology (Rho) A and protein kinase C (PKC) isoforms (α, βI, and βII), and also inhibited the membrane recruitment of Arf6 and RhoA in fMLP-stimulated neutrophils, but not in GTPγS-stimulated cell-free system. The cellular levels of GTP-bound Arf6 and GTP-bound RhoA were reduced by Fal-002-2. Fal-002-2 also attenuated the membrane recruitment of Rho-associated protein kinase 1, phosphorylation of myosin light chain 2 at Thr18/Ser19 and PLD1 at Thr147, and the interaction of Arf6 with both arfaptin 1 and phosphatidylinositol 4-phosphate 5-kinase 1A. The association between RhoA and Vav, the interaction of Vav with both Lyn and Lck, the membrane recruitment of Vav, and the phosphorylation of Vav at Tyr174, but not Src family at Tyr416, were all attenuated by Fal-002-2 in fMLP-stimulated neutrophils. These results indicate that Fal-002-2 is not a direct PLD inhibitor, but the inhibition of fMLP-stimulated PLD activity by Fal-002-2, which partly accounts for its suppression of O2 ?? generation, is attributable to the blockade of both Arf6 and RhoA activation and attenuation of the interaction of Arf6, RhoA and PKC isoforms with PLD1 in rat neutrophils.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700